nach oben

Clinical Oral Investigations

Erschienen in:

25.04.2018 | Review

Treatment modalities for burning mouth syndrome: a systematic review

verfasst von: Isadora Follak de Souza, Belkiss Câmara Mármora, Pantelis Varvaki Rados, Fernanda Visioli

Erschienen in: Clinical Oral Investigations | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

In the burning mouth syndrome (BMS), patients experience a burning sensation in the oral cavity with no associated injury or clinical manifestation. The etiology of this condition is still poorly understood, and therefore, treatment is challenging. The aim of this study is to perform a systematic review of treatment possibilities described in the literature for BMS.

Materials and methods

PubMed, Embase, and SciELO databases were searched for randomized clinical trials published between 1996 and 2016.

Results

Following application of inclusion and exclusion criteria, 29 papers were analyzed and divided into five subcategories according to the type of treatment described: antidepressants, alpha-lipoic acid, phytotherapeutic agents, analgesic and anti-inflammatory agents, and non-pharmacological therapies. In each category, the results found were compared with regard to the methodology employed, sample size, assessment method, presence or absence of adverse effects, and treatment outcomes.

Conclusions

The analysis revealed that the use of antidepressants and alpha-lipoic acid has been showing promising results; however, more studies are necessary before we can have a first-line treatment strategy for patients with BMS.

Clinical relevance

To review systematically the literature about Burning Mouth Syndrome treatment may aid the clinicians to choose the treatment modality to improve patients symptoms based on the best evidence.

Jimson S, Rajesh E, Krupaa RJ, Kasthuri M (2015) Burning mouth syndrome. J Pharm Bioallied Sci 7:S194–S196. https://doi.org/10.4103/0975-7406.155899 PubMedPubMedCentral

Oliveira GMR, Pereira HSC, Silva-Júnior GO et al (2013) Síndrome da Ardência Bucal: aspectos clínicos e tratamento. Revista do Hospital Universitário Pedro Ernesto, UERJ 12:21–29

Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA (2003) Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med Off Publ Am Assoc Oral Biol 14:275–291CrossRef

Marino R, Picci RL, Ferro G, Carezana C, Gandolfo S, Pentenero M (2015) Peculiar alexithymic traits in burning mouth syndrome: case–control study. Clin Oral Investig 19:1799–1805. https://doi.org/10.1007/s00784-015-1416-5 CrossRefPubMed

Barker K, Savage N (2005) Burning mouth syndrome: an update on recent findings. Aust Dent J 50:220–223. https://doi.org/10.1111/j.1834-7819.2005.tb00363.x CrossRefPubMed

López-Jornet P, Camacho-Alonso F, Andujar-Mateos P et al (2010) Burning mouth syndrome: an update. Med Oral Patol Oral Cir Bucal 15:e562–e568. https://doi.org/10.4317/medoral.15.e562 CrossRefPubMed

Aravindhan R, Vidyalakshmi S, Kumar MS, Satheesh C, Balasubramanium AM, Prasad VS (2014) Burning mouth syndrome: a review on its diagnostic and therapeutic approach. J Pharm Bioallied Sci 6:S21–S25. https://doi.org/10.4103/0975-7406.137255 CrossRefPubMedPubMedCentral

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006–1012. https://doi.org/10.1016/j.jclinepi.2009.06.005 CrossRefPubMed

Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T (2012) A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope 122:813–816. https://doi.org/10.1002/lary.22490 CrossRefPubMed

10.

Jurisic Kvesic A, Zavoreo I, Basic Kes V, Vucicevic Boras V, Ciliga D, Gabric D, Vrdoljak DV (2015) The effectiveness of acupuncture versus clonazepam in patients with burning mouth syndrome. Acupunct Med 33:289–292. https://doi.org/10.1136/acupmed-2015-010759 CrossRefPubMed

11.

Gremeau-Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, Laluque JF, Picard P, Pionchon P, Tubert S (2004) Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 108:51–57. https://doi.org/10.1016/j.pain.2003.12.002 CrossRefPubMed

12.

Rodríguez de Rivera Campillo E, López-López J, Chimenos-Küstner E (2010) Response to topical clonazepam in patients with burning mouth syndrome: a clinical study. Bull Group Int Rech Sci Stomatol Odontol 49:19–29PubMed

13.

Tammiala-Salonen T, Forssell H (1999) Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain 13:83–88. https://doi.org/10.1016/S0022-3913(99)70067-3 PubMed

14.

Maina G, Vitalucci A, Gandolfo S, Bogetto F (2002) Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 63:38–43. https://doi.org/10.4088/JCP.v63n0108 CrossRefPubMed

15.

Femiano F, Scully C (2002) Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 31:267–269. https://doi.org/10.1034/j.1600-0714.2002.310503.x

16.

Palacios-Sánchez B, Moreno-López L-A, Cerero-Lapiedra R et al (2015) Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial. Med Oral Patol Oral Cir Bucal 20:e435–e440. https://doi.org/10.4317/medoral.20410 CrossRefPubMedPubMedCentral

17.

López-D’alessandro E, Escovich L (2011) Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal 16:e635–e640. https://doi.org/10.4317/medoral.16942 CrossRefPubMed

18.

Cavalcanti DR, da Silveira FRX (2009) Alpha lipoic acid in burning mouth syndrome—a randomized double-blind placebo-controlled trial. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 38:254–261. https://doi.org/10.1111/j.1600-0714.2008.00735.x

19.

López-Jornet P, Camacho-Alonso F, Leon-Espinosa S (2009) Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil 36:52–57. https://doi.org/10.1111/j.1365-2842.2008.01914.x CrossRefPubMed

20.

Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S (2009) Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain Lond Engl 13:492–496. https://doi.org/10.1016/j.ejpain.2008.06.004 CrossRef

21.

Valenzuela S, Pons-Fuster A, López-Jornet P (2016) Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 45:528–533. https://doi.org/10.1111/jop.12412

22.

Cano-Carrillo P, Pons-Fuster A, López-Jornet P (2014) Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: a double-blind randomised. J Oral Rehabil 41:296–305. https://doi.org/10.1111/joor.12147 CrossRefPubMed

23.

da SLA, de SJTT, Teixeira MJ, de SSRDT (2014) The role of xerostomia in burning mouth syndrome: a case-control study. Arq Neuropsiquiatr 72:91–98. https://doi.org/10.1590/0004-282X20130218 CrossRef

24.

López-Jornet P, Camacho-Alonso F, Molino-Pagan D (2013) Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 42:295–301. https://doi.org/10.1111/jop.12002

25.

Spanemberg JC, López López J, de Figueiredo MAZ et al (2015) Efficacy of low-level laser therapy for the treatment of burning mouth syndrome: a randomized, controlled trial. J Biomed Opt 20:098001. https://doi.org/10.1117/1.JBO.20.9.098001 CrossRefPubMed

26.

Silvestre F-J, Silvestre-Rangil J, Tamarit-Santafé C, Bautista D (2012) Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal 17:e1–e4. https://doi.org/10.4317/medoral.17219 CrossRefPubMed

27.

Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A (2008) Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 37:395–401. https://doi.org/10.1111/j.1600-0714.2008.00663.x

28.

Spanemberg JC, Cherubini K, de Figueiredo MAZ, Gomes APN, Campos MM, Salum FG (2012) Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol 113:373–377. https://doi.org/10.1016/j.oooo.2011.09.005 CrossRefPubMed

29.

Treldal C, Jacobsen CB, Mogensen S, Rasmussen M, Jacobsen J, Petersen J, Lynge Pedersen AM, Andersen O (2016) Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome. Oral Dis 22:123–131. https://doi.org/10.1111/odi.12386 CrossRefPubMed

30.

Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A (2010) Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain 149:27–32. https://doi.org/10.1016/j.pain.2009.11.016 CrossRefPubMed

31.

Toida M, Kato K, Makita H, Long NK, Takeda T, Hatakeyama D, Yamashita T, Shibata T (2009) Palliative effect of lafutidine on oral burning sensation. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 38:262–268. https://doi.org/10.1111/j.1600-0714.2008.00736.x

32.

Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrassi A (1999) Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:683–686. https://doi.org/10.1016/S1079-2104(99)70010-7 CrossRefPubMed

33.

Sugaya NN, da Silva ÉFP, Kato IT et al (2016) Low intensity laser therapy in patients with burning mouth syndrome: a randomized, placebo-controlled study. Braz Oral Res 30:e108. https://doi.org/10.1590/1807-3107BOR-2016.vol30.0108 CrossRefPubMed

34.

Umezaki Y, Badran BW, DeVries WH et al (2016) The efficacy of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) for burning mouth syndrome (BMS): a randomized controlled single-blind study. Brain Stimul 9:234–242. https://doi.org/10.1016/j.brs.2015.10.005 CrossRefPubMed

35.

López-Jornet P, Camacho-Alonso F, Andujar-Mateos P (2011) A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis 17:277–282. https://doi.org/10.1111/j.1601-0825.2010.01737.x CrossRefPubMed

36.

Miziara ID, Filho BCA, Oliveira R, Rodrigues dos Santos RM (2009) Group psychotherapy: an additional approach to burning mouth syndrome. J Psychosom Res 67:443–448. https://doi.org/10.1016/j.jpsychores.2009.01.013 CrossRefPubMed

37.

Netto FOG, Diniz IMA, Grossmann SMC, de Abreu MHNG, do Carmo MAV, Aguiar MCF (2011) Risk factors in burning mouth syndrome: a case–control study based on patient records. Clin Oral Investig 15:571–575. https://doi.org/10.1007/s00784-010-0419-5 CrossRefPubMed

38.

Sun A, Wu K-M, Wang Y-P, Lin HP, Chen HM, Chiang CP (2013) Burning mouth syndrome: a review and update. J Oral Pathol Med 42:649–655. https://doi.org/10.1111/jop.12101 CrossRefPubMed

39.

Singh U, Jialal I (2008) Alpha-lipoic acid supplementation and diabetes. Nutr Rev 66:646–657. https://doi.org/10.1111/j.1753-4887.2008.00118.x CrossRefPubMedPubMedCentral

40.

Tirosh O, Sen CK, Roy S, Kobayashi MS, Packer L (1999) Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue. Free Radic Biol Med 26:1418–1426. https://doi.org/10.1016/S0891-5849(99)00014-3 CrossRefPubMed

41.

Arivazhagan P, Panneerselvam C (2000) Effect of DL-alpha-lipoic acid on neural antioxidants in aged rats. Pharmacol Res 42:219–222. https://doi.org/10.1006/phrs.2000.0679 CrossRefPubMed

42.

Marino R, Torretta S, Capaccio P, Pignataro L, Spadari F (2010) Different therapeutic strategies for burning mouth syndrome: preliminary data. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 39:611–616. https://doi.org/10.1111/j.1600-0714.2010.00922.x

43.

Pozza DH, Fregapani PW, Weber JBB et al (2008) Analgesic action of laser therapy (LLLT) in an animal model. Med Oral Patol Oral Cir Bucal 13:E648–E652PubMed

44.

Romeo U, Del Vecchio A, Capocci M et al (2010) The low level laser therapy in the management of neurological burning mouth syndrome. A pilot study. Ann Stomatol (Roma) 1:14–18

45.

Kim M-J, Kim J, Chang J-Y, Kim YY, Kho HS (2017) Polymorphisms of interleukin-1β and MUC7 genes in burning mouth syndrome. Clin Oral Investig 21:949–955. https://doi.org/10.1007/s00784-016-1866-4 CrossRefPubMed

Titel: Treatment modalities for burning mouth syndrome: a systematic review
verfasst von: Isadora Follak de Souza
Belkiss Câmara Mármora
Pantelis Varvaki Rados
Fernanda Visioli
Publikationsdatum: 25.04.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 5/2018
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-018-2454-6

Neu im Fachgebiet Zahnmedizin

19.04.2024 | Vorhofflimmern | Nachrichten

Newsletter bestellen

Springer Medizin

Treatment modalities for burning mouth syndrome: a systematic review

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter

Springer Medizin

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Gingival crevicular fluid levels of human beta-defensin-1 in type 2 diabetes mellitus and periodontitis

Relationship between caries experience and demarcated hypomineralised lesions (including MIH) in the permanent dentition of 15-year-olds

Cost assessment of a new oral care program in the intensive care unit to prevent ventilator-associated pneumonia

Activity of taurolidine gels on ex vivo periodontal biofilm

Evaluation of accuracy in implant site preparation performed in single- or multi-step drilling procedures

The effectiveness of two types of MADS for OSA therapy

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter